MariaDB (MRDB) 10-Q15 May 242024 Q2 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Mar. 31, 2024	May 07, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Securities Act File Number	001-41571
Entity Registrant Name	MariaDB plc
Entity Incorporation, State or Country Code	L2
Entity Address, Address Line One	699 Veterans Blvd
Entity Address, City or Town	Redwood City
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94063
City Area Code	855
Local Phone Number	562-7423
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Ordinary Shares Outstanding		68,997,819
Entity Central Index Key	0001929589
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--09-30
Amendment Flag	false
Ordinary Shares
Document Information [Line Items]
Title of 12(b) Security	Ordinary Shares, nominal value $0.01 per share
Trading Symbol	MRDB
Security Exchange Name	NYSE
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
Trading Symbol	MRDBW
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 1,758	$ 4,467
Accounts receivable, net	8,666	13,956
Prepaids and other current assets	7,637	5,780
Total current assets	18,061	24,203
Property and equipment, net	173	232
Operating lease right-of-use assets	136	509
Other noncurrent assets	5,190	4,848
Total assets	23,560	29,792
Current liabilities:
Accounts payable	4,471	4,378
Accrued expenses	5,845	6,450
Operating lease liabilities	147	539
Debt	25,583	15,855
Deferred revenue	29,226	29,828
Total current liabilities	65,272	57,050
Deferred revenue, net of current	14,779	16,793
Warrant liabilities	1,440	1,295
Deferred tax liability	0	173
Total liabilities	81,491	75,311
Commitments and contingencies
Stockholders’ Deficit:
Ordinary shares, par value of $0.01 per share; 67,749,429 and 67,713,368 shares issued and outstanding as of March 31, 2024 and September 30, 2023	674	674
Additional paid-in-capital	213,501	213,307
Accumulated deficit	(261,667)	(249,380)
Accumulated other comprehensive loss	(10,439)	(10,120)
Total stockholders’ deficit	(57,931)	(45,519)
Total liabilities and stockholders’ deficit	$ 23,560	$ 29,792

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Ordinary shares par value (in dollars per share)	$ 0.01	$ 0.01
Ordinary shares issued (in shares)	67,749,429	67,713,368
Ordinary shares outstanding (in shares)	67,749,429	67,713,368

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 13,585	$ 13,474	$ 27,197	$ 26,279
Cost of revenue:
Total cost of revenue	2,744	3,219	5,596	6,584
Gross profit	10,841	10,255	21,601	19,695
Operating expenses:
Research and development	3,886	9,274	9,202	18,747
Sales and marketing	4,418	7,289	8,691	14,175
General and administrative	3,641	6,716	8,535	12,219
Restructuring and other charges	475	0	3,242	0
Loss (gain) on divestitures	134	0	(799)	0
Total operating expense	12,554	23,279	28,871	45,141
Loss from operations	(1,713)	(13,024)	(7,270)	(25,446)
Other (expense) income:
Interest expense	(1,369)	(282)	(4,478)	(514)
Change in fair value of warrant liabilities	(809)	2,297	(170)	4,028
Other income (expense), net	379	(779)	(529)	(2,608)
Loss before income taxes	(3,512)	(11,788)	(12,447)	(24,540)
Income tax (expense) benefit	(7)	(62)	160	(6)
Net loss	$ (3,519)	$ (11,850)	$ (12,287)	$ (24,546)
Net loss per share attributable to ordinary shares - basic (in dollars per share)	$ (0.05)	$ (0.18)	$ (0.18)	$ (0.54)
Net loss per share attributable to ordinary shares - diluted (in dollars per share)	$ (0.05)	$ (0.18)	$ (0.18)	$ (0.54)
Weighted-average shares outstanding - basic (in shares)	67,744,195	66,575,652	67,733,643	45,125,926
Weighted-average shares outstanding - diluted (in shares)	67,744,195	66,575,652	67,733,643	45,125,926
Comprehensive Loss:
Net loss	$ (3,519)	$ (11,850)	$ (12,287)	$ (24,546)
Foreign currency translation adjustment, net of taxes	(174)	(1,220)	(319)	667
Unrealized loss from available-for-sale securities, net of taxes	0	0	0	(2,177)
Total comprehensive loss	(3,693)	(13,070)	(12,606)	(26,056)
Subscription
Revenue:
Total revenue	12,202	12,021	24,472	23,298
Cost of revenue:
Total cost of revenue	1,624	1,545	3,175	3,135
Services
Revenue:
Total revenue	1,383	1,453	2,725	2,981
Cost of revenue:
Total cost of revenue	$ 1,120	$ 1,674	$ 2,421	$ 3,449

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Previously Reported	Revision of Prior Period, Adjustment	Convertible preferred shares Series C preferred warrants	Convertible Preferred Shares Convertible preferred shares	Convertible Preferred Shares Convertible preferred shares Previously Reported	Convertible Preferred Shares Convertible preferred shares Revision of Prior Period, Adjustment	Convertible Preferred Shares Convertible preferred shares Series C preferred warrants	Ordinary Shares	Ordinary Shares Previously Reported	Ordinary Shares Revision of Prior Period, Adjustment	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Revision of Prior Period, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Previously Reported	Accumulated Deficit	Accumulated Deficit Previously Reported
Balance at the beginning of period (in shares) at Sep. 30, 2022					41,883,053	183,565,242	141,682,189
Balance at the beginning of period at Sep. 30, 2022					$ 206,969	$ 206,969
Increase (Decrease) in Temporary Equity
Exercise of Preferred Share Warrants (in shares)								539,627
Exercise of Series C - 2020 Preferred Share Warrants				$ 0				$ 3,516
Preferred stock conversion (in shares)					(42,422,680)
Preferred shares conversion					$ (210,485)
Balance at the end of period (in shares) at Dec. 31, 2022					0
Balance at the end of period at Dec. 31, 2022					$ 0
Balance at the beginning of period (in shares) at Sep. 30, 2022									13,864,344	60,764,711	46,900,367
Balance at the beginning of period at Sep. 30, 2022	$ (195,346)	$ (195,346)	$ 0						$ 139	$ 0	$ 139	$ 11,343	$ 11,482	$ (139)	$ (9,305)	$ (9,305)	$ (197,523)	$ (197,523)
Increase (Decrease) in Stockholders' Equity
Exercise of share options (in shares)									844,350
Exercise of share options	184								$ 8			176
Issuance of Ordinary Shares as consideration for CubeWerx and Sector 42 acquisition (in shares)									539,233
Issuance of Ordinary Shares as consideration for CubeWerx and Sector 42 acquisition	0								$ 5			(5)
Preferred stock conversion (in shares)									42,422,680
Preferred shares conversion	210,485								$ 424			210,061
Issuance of Ordinary Shares upon Business Combination including PIPE financing (in shares)									8,812,585
Issuance of Ordinary Shares upon Business Combination including PIPE financing (net of offering costs of $14.9 million)	(10,638)								$ 88			(10,726)
Share-based compensation	616											616
Other comprehensive income	(290)														(290)
Net loss	(12,696)																(12,696)
Balance at the end of period (in shares) at Dec. 31, 2022									66,483,192
Balance at the end of period at Dec. 31, 2022	(7,685)								$ 664			211,465			(9,595)		(210,219)
Balance at the beginning of period (in shares) at Sep. 30, 2022					41,883,053	183,565,242	141,682,189
Balance at the beginning of period at Sep. 30, 2022					$ 206,969	$ 206,969
Balance at the beginning of period (in shares) at Sep. 30, 2022									13,864,344	60,764,711	46,900,367
Balance at the beginning of period at Sep. 30, 2022	(195,346)	$ (195,346)	$ 0						$ 139	$ 0	$ 139	11,343	$ 11,482	$ (139)	(9,305)	$ (9,305)	(197,523)	$ (197,523)
Increase (Decrease) in Stockholders' Equity
Net loss	(24,546)
Balance at the end of period (in shares) at Mar. 31, 2023									66,872,785
Balance at the end of period at Mar. 31, 2023	(19,963)								$ 668			212,253			(10,815)		(222,069)
Balance at the beginning of period (in shares) at Dec. 31, 2022					0
Balance at the beginning of period at Dec. 31, 2022					$ 0
Balance at the beginning of period (in shares) at Dec. 31, 2022									66,483,192
Balance at the beginning of period at Dec. 31, 2022	(7,685)								$ 664			211,465			(9,595)		(210,219)
Increase (Decrease) in Stockholders' Equity
Exercise of share options (in shares)									389,593
Exercise of share options	214								$ 4			210
Adjustment to deferred offering costs	337											337
Share-based compensation	241											241
Other comprehensive income	(1,220)														(1,220)
Net loss	(11,850)																(11,850)
Balance at the end of period (in shares) at Mar. 31, 2023									66,872,785
Balance at the end of period at Mar. 31, 2023	(19,963)								$ 668			212,253			(10,815)		(222,069)
Balance at the beginning of period (in shares) at Sep. 30, 2023									67,713,368
Balance at the beginning of period at Sep. 30, 2023	(45,519)								$ 674			213,307			(10,120)		(249,380)
Increase (Decrease) in Stockholders' Equity
Exercise of share options (in shares)									24,016
Exercise of share options	11											11
Vesting of restricted stock units (in shares)									1,250
Share-based compensation	13											13
Other comprehensive income	(145)														(145)
Net loss	(8,768)																(8,768)
Balance at the end of period (in shares) at Dec. 31, 2023									67,738,634
Balance at the end of period at Dec. 31, 2023	(54,408)								$ 674			213,331			(10,265)		(258,148)
Balance at the beginning of period (in shares) at Sep. 30, 2023									67,713,368
Balance at the beginning of period at Sep. 30, 2023	$ (45,519)								$ 674			213,307			(10,120)		(249,380)
Increase (Decrease) in Stockholders' Equity
Exercise of share options (in shares)	24,124
Net loss	$ (12,287)
Balance at the end of period (in shares) at Mar. 31, 2024									67,749,429
Balance at the end of period at Mar. 31, 2024	(57,931)								$ 674			213,501			(10,439)		(261,667)
Balance at the beginning of period (in shares) at Dec. 31, 2023									67,738,634
Balance at the beginning of period at Dec. 31, 2023	(54,408)								$ 674			213,331			(10,265)		(258,148)
Increase (Decrease) in Stockholders' Equity
Exercise of share options (in shares)									108
Vesting of restricted stock units (in shares)									10,687
Share-based compensation	170											170
Other comprehensive income	(174)														(174)
Net loss	(3,519)																(3,519)
Balance at the end of period (in shares) at Mar. 31, 2024									67,749,429
Balance at the end of period at Mar. 31, 2024	$ (57,931)								$ 674			$ 213,501			$ (10,439)		$ (261,667)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Deficit (Parenthetical) $ in Millions	6 Months Ended
	Mar. 31, 2023 USD ($)
Statement of Stockholders' Equity [Abstract]
Offering costs	$ 14.9

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Operating activities:
Net loss			$ (12,287)	$ (24,546)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in allowance for doubtful accounts			(48)	732	$ 802
Depreciation and amortization			60	374
Non-cash lease expense			374	120
Stock-based compensation			183	857
Change in fair value of warrant liability	$ 809	$ (2,297)	170	(4,028)
Loss from disposal of property and equipment			0	48
Amortization of deferred commission			950	875
Investment income			0	(925)
Foreign currency loss, net			1,224	1,917
Non-cash interest expense, including interest expenses associated with debt issuance costs			3,067	0
Restructuring and other charges			933	0
Gain on divestitures			(933)	0
Deferred income tax			(171)	0
Changes in operating assets and liabilities:
Accounts receivable			5,508	(14,275)
Other current assets			(2,444)	(1,349)
Other noncurrent assets			(307)	(1)
Accounts payable and accrued expenses			(1,197)	(299)
Operating lease liability			(393)	(114)
Deferred revenue			(3,272)	11,166
Net cash used in operating activities			(8,583)	(29,448)
Investing activities:
Purchases of property and equipment			0	(5)
Disposal of investments			0	25,948
Net cash provided by investing activities			0	25,943
Financing activities:
Proceeds from stock options exercise			11	398
Settlement of warrant liabilities			0	(427)
Proceeds from exercise of warrants			0	2,867
Payment of offering costs related to the Business Combination			0	(5,417)
Proceeds from the Business Combination			0	10,509
Net proceeds from issuance of promissory note			23,993	0
Repayment of debt			(16,866)	(135)
Net cash provided by financing activities			7,138	7,795
Effect of exchange rate changes on cash and cash equivalents			(1,264)	657
Net (decrease) increase in cash and cash equivalents			(2,709)	4,947
Cash and cash equivalents at beginning of period			4,467	4,756	4,756
Cash and cash equivalents at end of period	$ 1,758	$ 9,703	1,758	9,703	$ 4,467
Supplemental disclosures of cash flow information:
Cash paid for income taxes			0	0
Cash paid for interest			1,105	451
Non-cash investing and financing activities:
Conversion of Convertible Preferred Shares to Ordinary Shares			0	210,485
Warrant liabilities assumed in the Business Combination			0	7,111
Net assets assumed in the Business Combination			0	883
Reclassification of deferred offering costs related to the Business Combination			0	9,165
Series C Preferred Shares
Non-cash investing and financing activities:
Issuance of Series C Preferred Shares – Exercise of Warrant Liabilities, Fair Value			$ 0	$ 649

Organization and Description of

Organization and Description of Business	6 Months Ended
Organization and Description of Business	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business MariaDB plc (“MariaDB” or the “Company”) provides one of the most popular general purpose relational databases. The Company’s operations consist of programming, development and sales of software programs, applications and tools related to enterprise database software. In addition, the Company provides user support, consultation and training for the software, applications, tools, and systems. The Company is active in development of both open source and closed source software. The Company is headquartered in Redwood City, California and Dublin, Ireland, with operations in other locations including Espoo, Finland, and Sofia, Bulgaria. Liquidity and Going Concern As of March 31, 2024, the Company had an accumulated deficit of $261.7 million and $1.8 million in cash and cash equivalents. The Company has determined our current cash and cash equivalents will not be sufficient to fund operations (including the repayment of the RP Note and related interest that was due in January 2024 (refer to Note 8 Debt for additional discussion)), for at least 12 months from the date these financial statements were issued (May 15, 2024), raising substantial doubt about our ability to continue as a going concern. The Company is currently in the process of being acquired and is seeking financing to avoid any potential shortfall of cash and cash equivalents to fund operations, for at least 12 months from the date the financial statements were issued.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying Unaudited Condensed Consolidated Financial Statements, including the accounts of MariaDB and its wholly-owned subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). All intercompany balances and transactions among have been eliminated in consolidation. Revenue Recognition Deferred revenues consist of customer contracts billed or cash received that will be recognized in the future under subscriptions existing at the balance sheet date. The current portion of deferred revenues represents amounts that are expected to be recognized within one year of the balance sheet date. As of March 31, 2024 and September 30, 2023, the balance of deferred revenue was $44.0 million and $46.6 million, respectively, which includes $11.9 million and $12.4 million of refundable customer deposits, respectively. Revenue recognized during the three months ended March 31, 2024 and 2023 that was included in the deferred revenue beginning balance of each year was $7.1 million and $6.7 million, respectively. Revenue recognized during the six months ended March 31, 2024 and 2023 that was included in the deferred revenue beginning balance of each year was $18.4 million and $16.7 million, respectively. Incremental direct costs of obtaining a contract are included in prepaid and other current assets and other noncurrent assets, respectively, in the Unaudited Condensed Consolidated Balance Sheets. The current and noncurrent deferred commissions had a balance of $5.3 million and $5.6 million as of March 31, 2024 and September 30, 2023, respectively. Concentration of Credit Risk As of March 31, 2024, two customers accounted for 39.5% of the total balance of accounts receivable, net. As of September 30, 2023, one customer accounted for 10.5% of the total balance of accounts receivable, net. For the three and six months ended March 31, 2024 and 2023, no customer accounted for more than 10% of the Company’s total consolidated revenues. Fair Value of Financial Instruments As of March 31, 2024 and September 30, 2023, the carrying value of the Company’s financial instruments included in current assets and current liabilities (including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and debt) approximate fair value due to the short-term nature of such items. Accounts Receivable, Net Accounts receivable, net was $8.7 million as of March 31, 2024 compared to $14.0 million as of September 30, 2023 as reported on the Unaudited Condensed Consolidated Balance Sheets. The following table presents the changes in the allowance for credit losses for the six months ended March 31, 2024 and the year ended September 30, 2023: March 31, September 30, (in thousands) Balance, beginning of period $ 1,386 $ 642 Change in provision for credit losses (48) 802 Less: write-offs, net of recoveries (555) (105) Foreign currency translation 215 47 Balance, end of period $ 998 $ 1,386 Prepaids and Other Current Assets Prepaid expenses and other current assets totaled $7.6 million and $5.8 million as of March 31, 2024 and September 30, 2023, respectively. Prepaid expenses totaled $5.6 million and $3.7 million as of March 31, 2024 and September 30, 2023, respectively. Prepaid expenses as of March 31, 2024 were primarily related to deferred legal fees related to the pending sale of the Company and deferred issuance costs in anticipation of additional financings. Prepaid expenses as of September 30, 2023 were primarily related to up-front payments made to third parties in the ordinary course of business. Other current assets primarily consisted of deferred commission totaling $1.9 million and $1.7 million as of March 31, 2024 and September 30, 2023, respectively. Other receivables totaled $0.1 million and $0.4 million as of March 31, 2024 and September 30, 2023, respectively.

Revenue

Revenue	6 Months Ended
Revenue	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The Company believes that the nature, amount, timing and uncertainty of its revenue and cash flows and how they are affected by economic factors is most appropriately depicted through the Company’s primary geographical markets . The Company’s primary geographical markets are North and South America (“Americas”); Europe, Middle East and Africa (“EMEA”); and Asia Pacific (“APAC”). The following table summarizes the disaggregation of revenue by geography for the three and six months ended March 31, 2024 and 2023 respectively. Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 (in thousands) (in thousands) EMEA $ 5,119 $ 4,562 $ 9,911 $ 9,211 Americas 5,795 6,510 12,065 12,473 APAC 2,671 2,402 5,221 4,595 Total revenue $ 13,585 $ 13,474 $ 27,197 $ 26,279 Revenue attributable to the United States comprised 39.6% and 42.9% of the total consolidated revenue for the three months ended March 31, 2024 and 2023, respectively. Revenue attributable to the United States comprised 41.1% and 42.6% of the total revenue for the six months ended March 31, 2024 and 2023, respectively. No other country outside of the United States comprised more than 10% of revenue for the three and six months ended March 31, 2024 and 2023. Revenue by location is determined by the billing address of the customer. Revenue from professional services recognized at a point in time amounted to $0.3 million and $0.1 million and revenue from professional services recognized over time amounted to $1.1 million and $1.4 million for the three months ended March 31, 2024 and 2023, respectively. Revenue from professional services recognized at a point in time amounted to $0.4 million and $0.3 million and revenue from professional services recognized over time amounted to $2.3 million and $2.7 million for the six months ended March 31, 2024 and 2023, respectively. Remaining Performance Obligations Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered as of the end of the reporting period. Remaining performance obligations estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, adjustments for revenue that have not materialized and adjustments for currency. As of March 31, 2024, approximately $57.5 million of revenue is expected to be recognized from remaining performance obligations. The Company expects to recognize revenue approximately 50.8% of these remaining performance obligations over the next 12 months. The Company’s subscription contracts are recognized ratably over the contract term. Accordingly, the majority of the Company’s noncurrent remaining performance obligation is expected to be recognized in the next 13 to 36 months with the remainder recognized thereafter.

Warrants

Warrants	6 Months Ended
Warrants	Mar. 31, 2024
Warrants
Warrants	Warrants Warrant information in the below table is presented as of March 31, 2024 and September 30, 2023. Warrants Outstanding Fair Value of Warrant Liabilities Warrants Number of Purchase price March 31, 2024 September 30, 2023 March 31, 2024 September 30, 2023 (in thousands) Kreos Rollover Warrant 190,559 € 2.28 190,559 190,559 $ 1 $ 1 Series C – 2017 1,215,345 € 0.04 — — — — Series C – 2020 786,234 € 5.22 — — — — Public Warrants 8,850,458 $ 11.50 8,850,458 8,850,458 781 709 Private Warrants 7,310,297 $ 11.50 7,310,297 7,310,297 658 585 18,352,893 16,351,314 16,351,314 $ 1,440 $ 1,295 The following table presents the change in the fair value of warrant liabilities for the six months ended March 31, 2024: Fair Value of Warrant Liabilities (in thousands) September 30, 2023 $ 1,295 Change in fair value (639) Foreign currency translation (10) December 31, 2023 646 Change in fair value 809 Foreign currency translation (15) March 31, 2024 $ 1,440 The following table presents the change in the fair value of warrant liabilities for the six months ended March 31, 2023: Fair Value of Warrant Liabilities (in thousands) September 30, 2022 $ 1,749 Change in fair value (1,731) Warrants assumed in the Business Combination 7,111 Settlement of 2017 Series C Warrants put option (427) Exercised (649) Foreign currency translation 182 December 31, 2022 6,235 Change in fair value (2,297) Foreign currency translation (19) March 31, 2023 $ 3,919 Fair values of the Public and Private Warrants were determined using publicly traded warrant prices at the end of each period. Fair values of the remaining warrants and option rights were determined using the Black-Scholes option-pricing model with the following input assumptions: Six Months Ended March 31, 2024 2023 Expected volatility range (weighted average) 44.07% 47.79% Dividend yield 0.00% 0.00% Risk-free interest rates range (weighted average) 4.89% 3.80% Expected term range (weighted average) 2.63 years 3.13 years Assumptions were weighted by the relative fair value of the instruments. An increase in the expected volatility, risk-free interest rates, and expected term would result in an increase to the estimated value of the warrants while an increase in the dividend yield would result in a decrease to the estimated value of the warrants.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
Stock-Based Compensation	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Legacy MariaDB Stock Option Plans During the six months ended March 31, 2023, 65,098 options were granted under the Global Share Option Plan 2017 ("2017 Plan"). No options were granted under the 2017 Plan during the six months ended March 31, 2024. No options were granted under the Global Share Option Plan 2017 USA ("2017 US Plan") during the six months ended March 31, 2024 and 2023. During the six months ended March 31, 2023, 58,182 options were granted under the Summer 2022 USA Share Option Plan ("2022 US Plan"). No options were granted under the 2022 US Plan during the six months ended March 31, 2024. MariaDB plc 2022 Equity Incentive Plan No RSUs or options were granted under the MariaDB plc 2022 Equity Incentive Plan ("2022 Equity Plan") during the six months ended March 31, 2023. During the six months ended March 31, 2024, 232,900 RSUs were granted under the 2022 Equity Plan. No options were granted under the 2022 Equity Plan during the six months ended March 31, 2024. Stock Options The following table summarizes stock option activity under the Company’s incentive plans for the six months ended March 31, 2024: Number Weighted Weighted- Aggregated (in years) (in thousands) Options outstanding, September 30, 2023 7,897,771 $ 1.28 Granted — $ — Exercised (24,124) $ 0.47 Forfeited (2,666,379) $ 1.80 Expired (461,160) $ 0.75 Options outstanding, March 31, 2024 4,746,108 $ 1.04 5.70 $ 72 Options Exercisable, March 31, 2024 4,365,686 $ 0.86 5.52 $ 72 Vested and expected to vest after March 31, 2024 4,746,108 $ 1.04 5.70 $ 72 The total intrinsic value of options exercised during the six months ended March 31, 2024 was nominal. The aggregate grant date fair value of stock options vested during the six months ended March 31, 2024 was approximately $0.3 million. As of March 31, 2024, there was approximately $0.2 million of unrecognized stock-based compensation expense related to outstanding stock options granted to employees that is expected to be recognized over a weighted-average period of 1.5 years. Fair Value Valuation Assumptions The fair value of options granted is estimated at the date of grant using the Black-Scholes option-pricing model with the following input assumptions: Six Months Ended March 31, 2024 2023 Range 1 Weighted Average 1 Range Weighted Dividend yield (%) 0% - 0% —% 0% - 0% 0% Expected volatility (%) 0.00% - 0.00% —% 44.90% - 47.26% 45.90% Risk–free interest rate (%) 0.00% - 0.00% —% 3.70% - 3.80% 3.76% Expected life of stock options (years) 0 - 0 — 5.00 - 7.00 5.88 Fair value of common stock $0.00 - $0.00 $— $4.16 - $4.16 $4.16 1 No options were granted during the six months ended March 31, 2024. Restricted Stock Units The RSUs vest over a four-year period, subject to the holder's continued service through the vesting dates. The following table summarizes RSU activity under the 2022 Equity Incentive Plan for the six months ended March 31, 2024: Number of RSUs Weighted Average Grant Date Fair Value Per Share Unvested outstanding, September 30, 2023 4,602,830 $ 0.91 Granted 232,900 $ 0.17 Vested (11,937) $ 0.89 Forfeited/canceled (1,075,739) $ 0.88 Unvested outstanding, March 31, 2024 3,748,054 $ 0.88 As of March 31, 2024, there was $1.8 million of unrecognized stock-based compensation expense relating to outstanding RSUs granted to employees, directors, and executives that is expected to be recognized over a weighted-average period of 1.81 years. Total stock-based compensation expense recognized in the Company’s Unaudited Condensed Consolidated Statements of Operations and comprehensive loss is as follows for the periods indicated: Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 (in thousands) (in thousands) Cost of revenue $ 12 $ 31 $ 97 $ 99 Research and development (122) 159 (288) 379 Sales and marketing 100 38 225 142 General and administrative 180 13 149 237 Total stock-based compensation expense $ 170 $ 241 $ 183 $ 857

Accrued Expenses

Accrued Expenses	6 Months Ended
Accrued Expenses	Mar. 31, 2024
Accrued Liabilities, Current [Abstract]
Accrued Expenses	Accrued Expenses The following represents the components of accrued expenses contained within our Unaudited Condensed Consolidated Balance Sheets as of the end of each period: March 31, 2024 September 30, 2023 (in thousands) Accrued payroll and payroll related liabilities $ 1,800 $ 3,577 Accrued bonuses 916 780 Accrued restructuring and other charges 302 — Taxes payable 494 494 Accrued interest expense 289 — Other accrued expenses 2,044 1,599 Total accrued expenses $ 5,845 $ 6,450

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company is subject to claims, legal proceedings, governmental actions, and assessments from time to time in the ordinary course of business, including without limitation, actions with respect to intellectual property, employment, regulatory, product liability and contractual matters. In connection with these matters, the Company regularly assesses the probability and amount (or range) of possible issues based on the developments in these matters and more generally the significance of these matters to the Company. A liability is recorded in the accompanying Unaudited Condensed Consolidated Financial Statements if it is determined that it is probable that a loss has been incurred and the amount (or range) of the loss can be reasonably estimated. The Company’s management currently does not believe that any such matters, individually or in the aggregate, will have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows; provided, however, if any such matters individually or in the aggregate are decided adversely to the Company, then such matters may have a material adverse effect. In January 2023, MariaDB received a demand letter on behalf of Houlihan Lokey Capital, Inc., a financial services company that advised Legacy MariaDB in connection with a financing transaction which closed in January 2022, for which that financial services company had provided advisory services and for which MariaDB paid its fee. The demand is for an additional fee based on a de-SPAC transaction which closed in December 2022. On July 11, 2023, Houlihan Lokey Capital, Inc. filed a lawsuit against the Company in the Supreme Court of the State of New York asserting claims against the Company for breach of contract and unjust enrichment and demand judgment against the Company in an unspecified amount exceeding $6.3 million, plus interest. The Company has answered the complaint and the matter is nearing the end of the fact discovery phase. At the current stage of the litigation, it is not possible to estimate the amount or range of possible loss that might result from an adverse judgment or a settlement of this matter. As of March 31, 2024, the Company accrued $1.0 million in other accrued expenses related to a settlement offer the Company made in this matter. In February 2023, a second financial services company sent MariaDB an additional invoice for approximately $1.3 million under the same circumstances as described in the matter above. MariaDB denies that it owes any additional fees, and no legal proceedings have been filed in connection with this fee claim. MariaDB intends to defend any legal proceedings that may be filed.

Debt

Debt	6 Months Ended
Debt	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt The components of debt are as follows: March 31, 2024 September 30, 2023 (in thousands) RP note $ 25,583 $ — Term loan — 15,855 Total 25,583 15,855 Less: Current portion (25,583) (15,855) Long-term debt $ — $ — Loan facility agreement with RP Ventures LLC (Purchased by Meridian Topco LLC) On October 10, 2023, the Company issued a senior secured promissory note, dated as of October 10, 2023 and amended on January 10, 2024, to RP Ventures in the principal amount of $26.5 million. RP Ventures acted as the initial Agent as defined in the RP Note (in such capacity, the “Agent”). On April 24, 2024, Meridian Topco LLC (“Meridian”), an affiliate of K1 Investment Management, LLC, a Delaware limited liability company (“K1”), purchased from RP Ventures, at a premium, all right, title and interest in, to and under the RP Note (the “RP Note Acquisition”). Further, Meridian Topco LLC became the Successor Agent (as defined in the note). The proceeds of the RP Note were used by the Company to repay all amounts outstanding under the term loan (the "Term Loan") from European Investment Bank ("EIB"), to pay RP Ventures a nonrefundable funding fee of $132,500, to pay or reimburse RP Ventures and Runa Capital Fund II, L.P. (“Runa”) for its out-of-pocket expenses related to the RP Note transaction, and to pay for working capital purposes as approved by the Company’s board of directors. Interest on the RP Note accrued on the principal amount at the rate of ten percent (10%) per annum and was payable commencing on January 1, 2024 and quarterly thereafter in arrears on the first business day of each calendar quarter and on the maturity date, whichever was earlier. While the RP Note remains outstanding, the note restricts the Company from pursuing or accepting any offer with respect to any recapitalization, reorganization, merger, business combination, purchase, sale, loan, notes issuance, issuance of other indebtedness or other financing or similar transaction, or to any acquisition by any person or group, which would result in any person or group becoming the beneficial owner of 2% or more of any class of equity interests or voting power or consolidated net income, revenue or assets, of the Company, in each case other than with the note holder. The RP Note contains certain customary representations and warranties and covenants of the Company. In addition, the Company has agreed to, among other things, provide to the note holder certain financial information, maintain minimum aggregate liquidity in an amount to be agreed upon after the Closing Date by the Board and the Agent or Successor Agent, and make disbursements and collect receivables based on budget amounts. The RP Note limits the ability of the Company to, among other things, (i) incur indebtedness, (ii) create certain liens, (iii) declare or distribute dividends or make certain other restricted payments, (iv) be party to a merger, consolidation, division or other fundamental change, (v) transfer, sell or lease Company assets, (vi) make certain modifications to the Company’s organizational documents or indebtedness, (vii) engage in certain transactions with affiliates, (viii) change the Company’s business, accounting or reporting practices, name or jurisdiction or organization, (ix) establish new bank accounts, and (x) establish or acquire any subsidiary. In addition, without the Agent or Successor Agent’s prior consent, the Company will be restricted in, among other things, taking part in transactions outside of the ordinary course of its existing business, making certain payments, or issuing equity interests. The RP Note provides for customary events of default, including for, among other things, payment defaults, breach of representations and certain covenants, cross defaults, insolvency, dissolution and bankruptcy, certain judgments against the Company, and material adverse changes. In the case of an event of default, the note holder may demand immediate repayment by the Company of all or part of the amounts outstanding, if any, under the RP Note. In connection with issuance of the RP Note, the Company and MariaDB USA. Inc. and certain other of the Company’s subsidiaries (the “Guarantors”) entered into a Guarantee and Collateral Agreement, pursuant to which the Company and each Guarantor pledged substantially all of their respective assets as collateral for the RP Note and each Guarantor guaranteed to the note holder the payment of all obligations arising from the RP Note. The RP Note was initially due on the earlier of (i) January 10, 2024, (ii) the occurrence of a "change of control" (as that term is defined in the RP Note), (iii) the occurrence of any breach of any of the documentation relating to the Company’s Term Loan or any demand for repayment of the Term Loan, and (iv) the date on which the RP Note is otherwise declared due and payable pursuant to its terms. On January 10, 2024, MariaDB entered into an amendment (the “First Amendment”) of the RP Note. The First Amendment, among and between the Company, RP Ventures, and other note parties to the RP Note, extended (i) the maturity date of the RP Note from January 10, 2024 to January 31, 2024, providing time for the Company to continue to work with parties related to the note holder on a recapitalization structure and (ii) the exclusivity period under the RP Note from January 10, 2024 to January 31, 2024. The Company paid RP Ventures a nonrefundable funding fee of $75,000 relating to the First Amendment. On January 31, 2024, the RP Note matured. The Company did not pay the outstanding principal, interest, and other applicable fees or charges due and payable on the RP Note. In addition, the Company and the Guarantors under the RP Note failed to comply with certain other obligations under the RP Note. This nonpayment and compliance failure gave rise to events of default under the RP Note. On February 5, 2024, to allow for further negotiations with respect to a transaction to restructure all or any material part of the obligations under the RP Note and any amendment or extension of the RP Note (the “RPV Transaction”), the Company and the Guarantors entered into the Forbearance Agreement with RP Ventures. Pursuant to the Forbearance Agreement, RP Ventures agreed not to exercise its rights and remedies in relation to the defaults under the RP Note identified in the Forbearance Agreement until February 21, 2024, subject to certain limitations and conditions. In addition, the Company agreed to pay RP Ventures a forbearance fee of $100,000 and to reimburse all reasonable and documented fees and out-of-pocket expenses of RP Ventures and any of its directors, officers, employees or agents, including its counsel, consultant and any other advisors, in connection with the Forbearance Agreement, the RP Note, the Guarantee and Collateral Agreement and other related RP Note documents. Under the terms of the Forbearance Agreement, interest on amounts due under the RP Note accrues at the default rate of 2% above the otherwise-applicable non-default interest rate of 10%. During the three and six month periods ended March 31, 2024, the Company paid RP Ventures approximately $2.0 million which included approximately $0.9 million related to principal and approximately $1.1 million of interest. During the three months ended March 31, 2024, the Company incurred cash interest expense of $0.8 million and non-cash interest expense (amortization of debt issuance cost) of $0.6 million on the RP Note. During the six months ended March 31, 2024, the Company incurred cash interest expense of $1.4 million and non-cash interest expense (amortization of debt issuance cost) of $3.1 million on the RP Note. The Company was not in compliance with the covenants of the RP Note as of March 31, 2024. Loan facility agreement with European Investment Bank The Term Loan was disbursed on October 11, 2019 and had a maturity date of October 11, 2023, at which time it was fully repaid. The Term Loan accrued interest between 6.0%-9.5% per annum, depending on MariaDB’s monthly recurring revenue. The effective interest rate on the Term Loan for the period the Term Loan was outstanding during the quarter ended December 31, 2023 and for the full quarter ended December 31, 2022 was 6.0%. As of September 30, 2023, the Company was in compliance with its debt covenants for the Term Loan. The schedule of required principal payments remaining on debt outstanding as of March 31, 2024 is as follows: Principal Payments ( in thousands ) 2024 $ 25,583 Total principal payments $ 25,583

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company maintains a full valuation allowance against its net deferred tax assets as of March 31, 2024 and September 30, 2023, based on the current assessment that it is not more likely than not these future benefits will be realized before expiration. No material income tax expense or benefit has been recorded given the valuation allowance position and projected taxable losses in the jurisdictions where the Company files income tax returns. The Company has not experienced any significant increases or decreases to its unrecognized tax benefits since September 30, 2023 and does not expect any within the next 12 months.

Related-Party Transactions

Related-Party Transactions	6 Months Ended
Related-Party Transactions	Mar. 31, 2024
Related Party Transactions [Abstract]
Related-Party Transactions	Related-Party Transactions Sales to and purchases from related parties are made on terms equivalent to those that prevail in arm’s length transactions. The Company had related party sales of $0.4 million and $0.2 million to a related party shareholder for the six months ended March 31, 2024 and 2023, respectively. The Company had no accounts receivable from related parties as of both periods ended March 31, 2024 and September 30, 2023. The Company incurred related party expenses of $0.8 million related to compensation of FTI Consulting, Inc. for Chief Restructuring Officer services, expenses related to the MariaDB Foundation and other expenses incurred in the ordinary course of business for the six month period ended March 31, 2024. The Company incurred expenses of $0.2 million related to the MariaDB Foundation for the six month period ended March 31, 2023. The Company had $0.3 million and no accounts payable to related parties as of March 31, 2024 and September 30, 2023, respectively. Outstanding balances are unsecured and interest free and settlement occurs in cash. There have been no guarantees provided or received for any related party trade receivables or payables. RP Note, First Amendment, and Forbearance Agreement On October 10, 2023, the Company issued the RP Note to RP Ventures, which had an initial maturity date of January 10, 24. On January 10, 2024, the RP Note maturity date was extended to January 31, 2024 pursuant to the First Amendment. On January 31, 2024, the RP Note matured. The Company did not pay the outstanding principal, interest, and other applicable fees or charges due and payable on the RP Note. In addition, the Company and the Guarantors under the RP Note failed to comply with certain other obligations under the RP Note. This nonpayment and compliance failure gave rise to events of default under the RP Note. On February 5, 2024, RP Ventures agreed not to exercise its rights and remedies in relation to the defaults under the RP Note identified in the Forbearance Agreement until February 21, 2024. See Note 8 - Debt for additional information and terms of the RP Note, First Amendment, and the Forbearance Agreement. Pursuant to Board appointment rights granted under the RP Note, RP Ventures appointed two directors, Michael Fanfant and Yakov Zubarev, to the Board on October 10, 2023. Mr. Fanfant and Mr. Zubarev have relationships with RP Ventures or certain Company shareholders and their affiliates. Mr. Fanfant is a shareholder of Runa Capital II (GP), the general partner of Runa Capital Fund II, L.P., and Runa Capital Opportunity I (GP), the general partner of Runa Capital Opportunity Fund I, L.P. and the managing shareholder of Runa Ventures I Limited, which collectively beneficially own more than 5% of the Company’s outstanding ordinary shares. Mr. Fanfant has also served as sole member and manager of RP Ventures since June 9, 2023. Mr. Zubarev is the brother of Ilya Zubarev, who is a shareholder in Runa Capital II (GP) and Runa Capital Opportunity I (GP), and one of four members of the investment committee of each of these entities that makes all investment and voting decisions relating to the Company’s ordinary shares held by Runa, Runa Capital Opportunity Fund I, L.P. and Runa Ventures I Limited. On April 24, 2024, Meridian, an affiliate of K1, purchased from RP Ventures, at a premium, all right, title and interest in, to and under the RP Note. Effective immediately following the closing of the RP Note Acquisition, Michael Fanfant and Yakov Zubarev resigned as directors of the Company. During the three and six month periods ended March 31, 2024, the Company paid RP Ventures approximately $2.0 million, which included approximately $0.9 million related to principal and approximately $1.1 million of interest.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
Net Loss Per Share	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive: Three and Six Months Ended March 31, 2024 2023 Warrants 16,351,314 16,351,314 Stock options 4,746,108 8,018,964 Restricted stock units 3,748,054 — Total 24,845,476 24,370,278 Warrant, stock option and share information is presented in the table above and its accompanying paragraphs as of March 31, 2024 and 2023, as applicable.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
Accumulated Other Comprehensive Loss	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following summarizes accumulated other comprehensive loss for the six months ended March 31, 2024 and 2023: Foreign Net Accumulated Balance at September 30, 2022 $ (11,482) $ 2,177 $ (9,305) Other comprehensive loss before reclassifications 1,887 — 1,887 Amounts reclassified from accumulated other comprehensive net loss — (2,177) (2,177) Net current period other comprehensive loss 1,887 (2,177) (290) Balance at December 31, 2022 (9,595) — (9,595) Other comprehensive loss (1,220) (1,220) Net current period (1,220) (1,220) Balance at March 31, 2023 $ (10,815) $ — $ (10,815) Balance at September 30, 2023 $ (10,120) $ — $ (10,120) Other comprehensive loss (145) (145) Net current period other comprehensive loss (145) (145) Balance at December 31, 2023 (10,265) — (10,265) Other comprehensive loss (174) (174) Net current period other comprehensive loss (174) — (174) Balance at March 31, 2024 $ (10,439) $ — $ (10,439)

Restructuring and other charges

Restructuring and other charges	6 Months Ended
Restructuring and other charges	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and other charges	Restructuring and other charges On October 12, 2023, the Company announced its plan to better align its workforce with the needs of its business and to reduce the Company’s operating costs. The plan included a reduction of the Company’s workforce by approximately 84 individuals. During the three months ended March 31, 2024, the Company recorded an additional restructuring charge of approximately $0.5 million related to a reduction of the workforce of approximately 12 individuals. The total restructuring charge for the six months ended March 31, 2024 was approximately $3.2 million, which was related primarily to headcount. The Company believes it restructuring efforts will be substantially completed by June 30, 2024. The following table presents the changes in accrued restructuring and other charges for the six months ended March 31, 2024: March 31, 2024 (in thousands) Balance, beginning of period $ — Net charges 3,242 Cash payments (2,940) Balance, end of period $ 302

Divestitures

Divestitures	6 Months Ended
Divestitures	Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Divestitures	Divestitures SkySQL On November 17, 2023, the Company entered into an Asset Purchase Agreement (“APA”) by and among MariaDB plc, MariaDB USA, Inc. and SkyDB, Inc. (“Sky”), completing the divestiture of the SkySQL business. Under the terms of the APA, Sky purchased all of the intellectual property, technology, operational contracts and other assets related to the SkySQL business in exchange for: (a) a to-be issued minority equity interest of ten (10%) percent of the common equity of Sky upon a third-party financing of Sky; and (b) the release and extinguishment of severance obligations for certain former Company employees who chose to become employees of Sky. All parties to the APA are subject to non-competition and non-solicitation covenants for twelve months following the effective date of the APA. Under the revenue sharing and customer transition provisions of the APA, the Company is entitled to 30% of the net revenues of any assigned customer agreement. The Company will have no seat on the Board of Directors or any significant influence over Sky's' financial or operational decisions. The minority interest in Sky is considered immaterial to the financial statements. The net book value of the assets related to the Sky business were all previously written off as a result of the annual goodwill impairment analysis as of September 30, 2023. In the three month period ended December 31, 2023, the Company reported a gain on the divestiture of the business of approximately $0.9 million related to the release and extinguishment of severance obligations for certain former Company employees who chose to become employees of Sky. The divestiture did not represent a strategic shift; therefore the operating results of SkySQL did not qualify for reporting as discontinued operations. CubeWerx On December 30, 2023, the Company agreed to sell, assign and transfer all of the purchased contracts, intellectual property and servers/hardware of its Canadian subsidiary for a nominal amount of consideration. As part of the divestiture, the Company is legally obligated to provide the buyer with a loan of approximately $0.6 million. The loan is interest bearing and matures in July 2029. The Company is also required to subscribe to 10% ownership of the buyer’s newly formed company. The investment will be considered immaterial to the Company’s financial statements. The Company will have no seat on the Board of Directors or any significant influence over its financial or operational decisions. The assets of the divested business were all previously written off as a result of the annual goodwill impairment analysis as of September 30, 2023. No gain or loss was reported on the sale of the company. The divestiture did not represent a strategic shift; therefore the operating results of the divested company did not qualify as discontinued operations.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying Unaudited Condensed Consolidated Financial Statements, including the accounts of MariaDB and its wholly-owned subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). All intercompany balances and transactions among have been eliminated in consolidation.
Revenue Recognition	Revenue Recognition Deferred revenues consist of customer contracts billed or cash received that will be recognized in the future under subscriptions existing at the balance sheet date. The current portion of deferred revenues represents amounts that are expected to be recognized within one year of the balance sheet date. As of March 31, 2024 and September 30, 2023, the balance of deferred revenue was $44.0 million and $46.6 million, respectively, which includes $11.9 million and $12.4 million of refundable customer deposits, respectively. Revenue recognized during the three months ended March 31, 2024 and 2023 that was included in the deferred revenue beginning balance of each year was $7.1 million and $6.7 million, respectively. Revenue recognized during the six months ended March 31, 2024 and 2023 that was included in the deferred revenue beginning balance of each year was $18.4 million and $16.7 million, respectively.
Fair Value of Financial Instruments	Fair Value of Financial Instruments As of March 31, 2024 and September 30, 2023, the carrying value of the Company’s financial instruments included in current assets and current liabilities (including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and debt) approximate fair value due to the short-term nature of such items.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
Summary of Significant Accounting Policies (Tables)	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of changes in allowance for credit losses	The following table presents the changes in the allowance for credit losses for the six months ended March 31, 2024 and the year ended September 30, 2023: March 31, September 30, (in thousands) Balance, beginning of period $ 1,386 $ 642 Change in provision for credit losses (48) 802 Less: write-offs, net of recoveries (555) (105) Foreign currency translation 215 47 Balance, end of period $ 998 $ 1,386

Revenue (Tables)

Revenue (Tables)	6 Months Ended
Revenue (Tables)	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of disaggregation of revenue	The following table summarizes the disaggregation of revenue by geography for the three and six months ended March 31, 2024 and 2023 respectively. Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 (in thousands) (in thousands) EMEA $ 5,119 $ 4,562 $ 9,911 $ 9,211 Americas 5,795 6,510 12,065 12,473 APAC 2,671 2,402 5,221 4,595 Total revenue $ 13,585 $ 13,474 $ 27,197 $ 26,279

Warrants (Tables)

Warrants (Tables)	6 Months Ended
Warrants (Tables)	Mar. 31, 2024
Warrants
Schedule of warrants issued and outstanding	Warrant information in the below table is presented as of March 31, 2024 and September 30, 2023. Warrants Outstanding Fair Value of Warrant Liabilities Warrants Number of Purchase price March 31, 2024 September 30, 2023 March 31, 2024 September 30, 2023 (in thousands) Kreos Rollover Warrant 190,559 € 2.28 190,559 190,559 $ 1 $ 1 Series C – 2017 1,215,345 € 0.04 — — — — Series C – 2020 786,234 € 5.22 — — — — Public Warrants 8,850,458 $ 11.50 8,850,458 8,850,458 781 709 Private Warrants 7,310,297 $ 11.50 7,310,297 7,310,297 658 585 18,352,893 16,351,314 16,351,314 $ 1,440 $ 1,295
Schedule of fair values for warrant liabilities	The following table presents the change in the fair value of warrant liabilities for the six months ended March 31, 2024: Fair Value of Warrant Liabilities (in thousands) September 30, 2023 $ 1,295 Change in fair value (639) Foreign currency translation (10) December 31, 2023 646 Change in fair value 809 Foreign currency translation (15) March 31, 2024 $ 1,440 The following table presents the change in the fair value of warrant liabilities for the six months ended March 31, 2023: Fair Value of Warrant Liabilities (in thousands) September 30, 2022 $ 1,749 Change in fair value (1,731) Warrants assumed in the Business Combination 7,111 Settlement of 2017 Series C Warrants put option (427) Exercised (649) Foreign currency translation 182 December 31, 2022 6,235 Change in fair value (2,297) Foreign currency translation (19) March 31, 2023 $ 3,919
Schedule of fair values of warrants and option rights were determined using the Black-Scholes option-pricing model with the input assumptions	Fair values of the Public and Private Warrants were determined using publicly traded warrant prices at the end of each period. Fair values of the remaining warrants and option rights were determined using the Black-Scholes option-pricing model with the following input assumptions: Six Months Ended March 31, 2024 2023 Expected volatility range (weighted average) 44.07% 47.79% Dividend yield 0.00% 0.00% Risk-free interest rates range (weighted average) 4.89% 3.80% Expected term range (weighted average) 2.63 years 3.13 years

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
Stock-Based Compensation (Tables)	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of stock option activity	The following table summarizes stock option activity under the Company’s incentive plans for the six months ended March 31, 2024: Number Weighted Weighted- Aggregated (in years) (in thousands) Options outstanding, September 30, 2023 7,897,771 $ 1.28 Granted — $ — Exercised (24,124) $ 0.47 Forfeited (2,666,379) $ 1.80 Expired (461,160) $ 0.75 Options outstanding, March 31, 2024 4,746,108 $ 1.04 5.70 $ 72 Options Exercisable, March 31, 2024 4,365,686 $ 0.86 5.52 $ 72 Vested and expected to vest after March 31, 2024 4,746,108 $ 1.04 5.70 $ 72
Schedule of fair valuation assumptions for stock options	The fair value of options granted is estimated at the date of grant using the Black-Scholes option-pricing model with the following input assumptions: Six Months Ended March 31, 2024 2023 Range 1 Weighted Average 1 Range Weighted Dividend yield (%) 0% - 0% —% 0% - 0% 0% Expected volatility (%) 0.00% - 0.00% —% 44.90% - 47.26% 45.90% Risk–free interest rate (%) 0.00% - 0.00% —% 3.70% - 3.80% 3.76% Expected life of stock options (years) 0 - 0 — 5.00 - 7.00 5.88 Fair value of common stock $0.00 - $0.00 $— $4.16 - $4.16 $4.16 1 No options were granted during the six months ended March 31, 2024.
Schedule of RSU activity	The RSUs vest over a four-year period, subject to the holder's continued service through the vesting dates. The following table summarizes RSU activity under the 2022 Equity Incentive Plan for the six months ended March 31, 2024: Number of RSUs Weighted Average Grant Date Fair Value Per Share Unvested outstanding, September 30, 2023 4,602,830 $ 0.91 Granted 232,900 $ 0.17 Vested (11,937) $ 0.89 Forfeited/canceled (1,075,739) $ 0.88 Unvested outstanding, March 31, 2024 3,748,054 $ 0.88
Schedule of stock-based compensation expense	Total stock-based compensation expense recognized in the Company’s Unaudited Condensed Consolidated Statements of Operations and comprehensive loss is as follows for the periods indicated: Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 (in thousands) (in thousands) Cost of revenue $ 12 $ 31 $ 97 $ 99 Research and development (122) 159 (288) 379 Sales and marketing 100 38 225 142 General and administrative 180 13 149 237 Total stock-based compensation expense $ 170 $ 241 $ 183 $ 857

Accrued Expenses (Tables)

Accrued Expenses (Tables)	6 Months Ended
Accrued Expenses (Tables)	Mar. 31, 2024
Accrued Liabilities, Current [Abstract]
Schedule of components of accrued expenses	The following represents the components of accrued expenses contained within our Unaudited Condensed Consolidated Balance Sheets as of the end of each period: March 31, 2024 September 30, 2023 (in thousands) Accrued payroll and payroll related liabilities $ 1,800 $ 3,577 Accrued bonuses 916 780 Accrued restructuring and other charges 302 — Taxes payable 494 494 Accrued interest expense 289 — Other accrued expenses 2,044 1,599 Total accrued expenses $ 5,845 $ 6,450

Debt (Tables)

Debt (Tables)	6 Months Ended
Debt (Tables)	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of debt	The components of debt are as follows: March 31, 2024 September 30, 2023 (in thousands) RP note $ 25,583 $ — Term loan — 15,855 Total 25,583 15,855 Less: Current portion (25,583) (15,855) Long-term debt $ — $ —
Schedule of principal payments remaining on debt outstanding	The schedule of required principal payments remaining on debt outstanding as of March 31, 2024 is as follows: Principal Payments ( in thousands ) 2024 $ 25,583 Total principal payments $ 25,583

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
Net Loss Per Share (Tables)	Mar. 31, 2024
Earnings Per Share [Abstract]
Summary of potentially dilutive securities excluded from computation of diluted net loss per share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive: Three and Six Months Ended March 31, 2024 2023 Warrants 16,351,314 16,351,314 Stock options 4,746,108 8,018,964 Restricted stock units 3,748,054 — Total 24,845,476 24,370,278

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of accumulated other comprehensive income (loss)	The following summarizes accumulated other comprehensive loss for the six months ended March 31, 2024 and 2023: Foreign Net Accumulated Balance at September 30, 2022 $ (11,482) $ 2,177 $ (9,305) Other comprehensive loss before reclassifications 1,887 — 1,887 Amounts reclassified from accumulated other comprehensive net loss — (2,177) (2,177) Net current period other comprehensive loss 1,887 (2,177) (290) Balance at December 31, 2022 (9,595) — (9,595) Other comprehensive loss (1,220) (1,220) Net current period (1,220) (1,220) Balance at March 31, 2023 $ (10,815) $ — $ (10,815) Balance at September 30, 2023 $ (10,120) $ — $ (10,120) Other comprehensive loss (145) (145) Net current period other comprehensive loss (145) (145) Balance at December 31, 2023 (10,265) — (10,265) Other comprehensive loss (174) (174) Net current period other comprehensive loss (174) — (174) Balance at March 31, 2024 $ (10,439) $ — $ (10,439)

Restructuring and other charg_2

Restructuring and other charges (Tables)	6 Months Ended
Restructuring and other charges (Tables)	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of restructuring reserve by type of cost	The following table presents the changes in accrued restructuring and other charges for the six months ended March 31, 2024: March 31, 2024 (in thousands) Balance, beginning of period $ — Net charges 3,242 Cash payments (2,940) Balance, end of period $ 302

Organization and Description _2

Organization and Description of Business (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Long-term Debt
Accumulated deficit	$ 261,667	$ 249,380
Cash and cash equivalents	$ 1,758	$ 4,467

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Summary of Significant Accounting Policies
Contract liabilities	$ 44,000		$ 44,000		$ 46,600
Refundable customer deposits	11,900		11,900		12,400
Revenue recognized	7,100	$ 6,700	18,400	$ 16,700
Accounts receivable, net	8,666		8,666		13,956
Prepaids and other current assets	7,637		7,637		5,780
Prepaid expenses	5,600		5,600		3,700
Deferred commissions	1,900		1,900		1,700
Other receivables	100		100		400
Deferred commissions
Summary of Significant Accounting Policies
Deferred contract cost	$ 5,300		$ 5,300		$ 5,600
Accounts Receivable \| Customer Concentration Risk \| Customer 1
Summary of Significant Accounting Policies
Revenue percentage					10.50%
Accounts Receivable \| Customer Concentration Risk \| Two Customers
Summary of Significant Accounting Policies
Revenue percentage			39.50%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Changes in Allowance for Credit Losses (Details) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance, beginning of period	$ 1,386	$ 642	$ 642
Change in provision for credit losses	(48)	$ 732	802
Less: write-offs, net of recoveries	(555)		(105)
Foreign currency translation	215		47
Balance, end of period	$ 998		$ 1,386

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue by Geography (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 13,585	$ 13,474	$ 27,197	$ 26,279
EMEA
Revenue
Total revenue	5,119	4,562	9,911	9,211
Americas
Revenue
Total revenue	5,795	6,510	12,065	12,473
APAC
Revenue
Total revenue	$ 2,671	$ 2,402	$ 5,221	$ 4,595

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue
Revenue	$ 13,585	$ 13,474	$ 27,197	$ 26,279
Revenue remaining performance obligation	$ 57,500		$ 57,500
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue
Revenue remaining performance obligation percentage	50.80%		50.80%
Performance obligation expected timing of satisfaction, period	12 months		12 months
Minimum \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01
Revenue
Performance obligation expected timing of satisfaction, period	13 months		13 months
Maximum \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01
Revenue
Performance obligation expected timing of satisfaction, period	36 months		36 months
Services
Revenue
Revenue	$ 1,383	1,453	$ 2,725	2,981
Services \| Transferred at Point in Time
Revenue
Revenue	300	100	400	300
Services \| Transferred over Time
Revenue
Revenue	$ 1,100	$ 1,400	$ 2,300	$ 2,700
Geographic Concentration Risk \| Revenue Benchmark \| United States
Revenue
Revenue percentage	39.60%	42.90%	41.10%	42.60%

Warrants - Issued and Outstandi

Warrants - Issued and Outstanding (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Mar. 31, 2024 € / shares shares	Mar. 31, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of warrants issued (in shares)	18,352,893
Warrants outstanding (in shares)		16,351,314	16,351,314
Fair Value of Warrant Liabilities \| $		$ 1,440	$ 1,295
Kreos Rollover Warrant
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of warrants issued (in shares)	190,559
Purchase price per share (in USD or EUR per share) \| € / shares	€ 2.28
Warrants outstanding (in shares)		190,559	190,559
Fair Value of Warrant Liabilities \| $		$ 1	$ 1
Series C – 2017
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of warrants issued (in shares)	1,215,345
Purchase price per share (in USD or EUR per share) \| € / shares	€ 0.04
Warrants outstanding (in shares)		0	0
Fair Value of Warrant Liabilities \| $		$ 0	$ 0
Series C – 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of warrants issued (in shares)	786,234
Purchase price per share (in USD or EUR per share) \| € / shares	€ 5.22
Warrants outstanding (in shares)		0	0
Fair Value of Warrant Liabilities \| $		$ 0	$ 0
Public Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of warrants issued (in shares)	8,850,458
Purchase price per share (in USD or EUR per share) \| $ / shares		$ 11.50
Warrants outstanding (in shares)		8,850,458	8,850,458
Fair Value of Warrant Liabilities \| $		$ 781	$ 709
Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of warrants issued (in shares)	7,310,297
Purchase price per share (in USD or EUR per share) \| $ / shares		$ 11.50
Warrants outstanding (in shares)		7,310,297	7,310,297
Fair Value of Warrant Liabilities \| $		$ 658	$ 585

Warrants - Fair Value of Warran

Warrants - Fair Value of Warrant Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]					Change in fair value
Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 646	$ 1,295	$ 6,235	$ 1,749	$ 1,749
Change in fair value	809	(639)	(2,297)	(1,731)
Warrants assumed in the Business Combination				7,111
Settlement of 2017 Series C Warrants put option				(427)
Exercised				(649)
Foreign currency translation	(15)	(10)	(19)	182
Ending balance	$ 1,440	$ 646	$ 3,919	$ 6,235	$ 3,919

Warrants - Fair Value Assumptio

Warrants - Fair Value Assumptions (Details)	Mar. 31, 2024	Mar. 31, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Term of warrants	2 years 7 months 17 days	3 years 1 month 17 days
Expected volatility range (weighted average)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.4407	0.4779
Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0
Risk-free interest rates range (weighted average)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0489	0.0380

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock-Based Compensation
Number of shares granted	0
Intrinsic value of options exercised	$ 0
Grant date fair value of stock options vested	0.3
Unrecognized stock-based compensation expense	$ 0.2
Unrecognized stock-based compensation expense recognition period	1 year 6 months
Restricted stock units
Stock-Based Compensation
Granted (in shares)	232,900
Unrecognized stock-based compensation expense relating to outstanding RSUs	$ 1.8
Unrecognized stock-based compensation expense recognition period	1 year 9 months 21 days
2017 Plan
Stock-Based Compensation
Number of shares granted	0	65,098
2017 US Plan
Stock-Based Compensation
Number of shares granted	0	0
2022 US Plan
Stock-Based Compensation
Number of shares granted	0	58,182
2022 Equity Incentive Plan
Stock-Based Compensation
Number of shares granted	0	0
2022 Equity Incentive Plan \| Restricted stock units
Stock-Based Compensation
Granted (in shares)	232,900	0

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Mar. 31, 2024
Number of Shares
Options outstanding, beginning of period (in shares)	7,897,771
Granted (in shares)	0
Exercised (in shares)	(24,124)
Forfeited (in shares)	(2,666,379)
Expired (in shares)	(461,160)
Options outstanding, end of period (in shares)	4,746,108
Options Exercisable, end of period (in shares)	4,365,686
Vested and expected to vest after period end (in shares)	4,746,108
Weighted Average Exercise Price Per Share
Options outstanding, beginning of period (in dollars per share)	$ 1.28
Granted (in dollars per share)	0
Exercised (in dollars per share)	0.47
Forfeited (in dollars per share)	1.80
Expired (in dollars per share)	0.75
Options outstanding, end of period (in dollars per share)	1.04
Options Exercisable, end of period (in dollars per share)	0.86
Vested and expected to vest after period end (in dollars per share)	$ 1.04
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted average remaining contractual life, options outstanding	5 years 8 months 12 days
Weighted average remaining contractual life, options exercisable	5 years 6 months 7 days
Weighted average remaining contractual life, options vested and expected to vest	5 years 8 months 12 days
Aggregated intrinsic value, options outstanding	$ 72
Aggregated intrinsic value, options exercisable	72
Aggregated intrinsic value, options vested and expected to vest	$ 72

Stock-Based Compensation - Fair

Stock-Based Compensation - Fair Value Valuation Assumptions (Details) - Stock options - $ / shares	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Fair value valuation assumptions
Minimum Expected volatility (%)	0%	44.90%
Maximum Expected volatility (%)	0%	47.26%
Minimum Risk-free interest rate (%)	0%	3.70%
Maximum Risk-free interest rate (%)	0%	3.80%
Minimum
Fair value valuation assumptions
Dividend yield (%)	0%	0%
Expected life of stock options (years)	0 years	5 years
Fair value of common stock (in dollars per share)	$ 0	$ 4.16
Maximum
Fair value valuation assumptions
Dividend yield (%)	0%	0%
Expected life of stock options (years)	0 years	7 years
Fair value of common stock (in dollars per share)	$ 0	$ 4.16
Weighted average
Fair value valuation assumptions
Dividend yield (%)	0%	0%
Weighted average Expected volatility (%)	0%	45.90%
Risk-free interest rate (%)	0%	3.76%
Expected life of stock options (years)	0 years	5 years 10 months 17 days
Fair value of common stock (in dollars per share)	$ 0	$ 4.16

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details) - Restricted stock units	6 Months Ended
	Mar. 31, 2024 $ / shares shares
Stock-Based Compensation
Vesting period	4 years
Number of RSUs
Unvested outstanding, beginning of period (in shares) \| shares	4,602,830
Granted (in shares) \| shares	232,900
Vested (in shares) \| shares	(11,937)
Forfeited/cancelled (in shares) \| shares	(1,075,739)
Unvested outstanding, end of period (in shares) \| shares	3,748,054
Weighted Average Grant Date Fair Value
Unvested, beginning of period (in dollars per share) \| $ / shares	$ 0.91
Granted (in dollars per share) \| $ / shares	0.17
Vested (in dollars per share) \| $ / shares	0.89
Forfeited/cancelled (in dollars per share) \| $ / shares	0.88
Unvested, end of period (in dollars per share) \| $ / shares	$ 0.88

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Stock-based compensation expense
Total stock-based compensation expense	$ 170	$ 241	$ 183	$ 857
Cost of revenue
Stock-based compensation expense
Total stock-based compensation expense	12	31	97	99
Research and development
Stock-based compensation expense
Total stock-based compensation expense	(122)	159	(288)	379
Sales and marketing
Stock-based compensation expense
Total stock-based compensation expense	100	38	225	142
General and administrative
Stock-based compensation expense
Total stock-based compensation expense	$ 180	$ 13	$ 149	$ 237

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Accrued Liabilities, Current [Abstract]
Accrued payroll and payroll related liabilities	$ 1,800	$ 3,577
Accrued bonuses	916	780
Accrued restructuring and other charges	302	0
Taxes payable	494	494
Accrued interest expense	289	0
Other accrued expenses	2,044	1,599
Accrued expenses	$ 5,845	$ 6,450

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions		1 Months Ended
	Jul. 11, 2023	Feb. 28, 2023	Mar. 31, 2024
Houlihan Lokey Capital
Loss Contingencies [Line Items]
Estimated litigation liability			$ 1
Houlihan Lokey Capital \| Minimum
Loss Contingencies [Line Items]
Amount of claims for additional service fees	$ 6.3
Second financial services company
Loss Contingencies [Line Items]
Amount of claims for additional service fees		$ 1.3

Debt - Components of Long-Term

Debt - Components of Long-Term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Long-term Debt
Term loan	$ 25,583
Total	25,583	$ 15,855
Less: Current portion	(25,583)	(15,855)
Long-term debt, net of current	0	0
Senior Secured Promissory Note \| Senior Notes
Long-term Debt
RP note	25,583	0
Term loan
Long-term Debt
Term loan	$ 0	$ 15,855

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
Debt - Additional Information (Details) - USD ($)	Mar. 31, 2024	Jan. 10, 2024	Mar. 31, 2024	Feb. 05, 2024	Jan. 31, 2024	Dec. 31, 2023	Oct. 10, 2023	Dec. 31, 2022	Oct. 11, 2019
Senior Secured Promissory Note \| Senior Notes
Long-term Debt
Principal amount							$ 26,500,000
Nonrefundable fee							$ 132,500
Interest rate, stated percentage							10%
Ownership interest, maximum threshold restricted to undesignated parties		2%
Nonrefundable funding fee		$ 75,000
Forbearance fee					$ 100,000
Interest rate, stated percentage above non default rate				2%
Interest expense	$ 800,000		$ 1,400,000
Amortization of debt issuance costs	600,000		3,100,000
Senior Secured Promissory Note \| Senior Notes \| Related Party
Long-term Debt
Repayments of debt	2,000,000		2,000,000
Debt instrument, repaid, principal	900,000		900,000
Interest expense	$ 1,100,000		$ 1,100,000
Term loan
Long-term Debt
Effective interest rate						6%		6%
Term loan \| Minimum
Long-term Debt
Interest rate, stated percentage									6%
Term loan \| Maximum
Long-term Debt
Interest rate, stated percentage									9.50%

Debt - Principal Payments (Deta

Debt - Principal Payments (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Debt Disclosure [Abstract]
2024	$ 25,583
Total	$ 25,583

Related-Party Transactions (Det

Related-Party Transactions (Details) $ in Thousands	3 Months Ended		6 Months Ended
Related-Party Transactions (Details) $ in Thousands	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Oct. 10, 2023 director	Sep. 30, 2023 USD ($)
Related-Party Transactions
Total revenue	$ 13,585	$ 13,474	$ 27,197	$ 26,279
Accounts receivable, net	8,666		8,666			$ 13,956
Related party transaction, amounts of transaction			800	200
Accounts payable	4,471		4,471			4,378
Senior Secured Promissory Note \| Senior Notes
Related-Party Transactions
Interest expense	800		1,400
Related Party
Related-Party Transactions
Total revenue			400	$ 200
Accounts receivable, net	0		0			0
Accounts payable	300		300			$ 0
Related party ownership interest in outstanding shares					5%
Related Party \| Senior Secured Promissory Note \| Senior Notes
Related-Party Transactions
Repayments of debt	2,000		2,000
Debt instrument, repaid, principal	900		900
Interest expense	$ 1,100		$ 1,100
Director
Related-Party Transactions
Number of directors appointed to board \| director					2

Net Loss Per Share - Potentiall

Net Loss Per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Potentially dilutive securities excluded from computation of diluted net loss per share
Anti-dilutive securities (in shares)	24,845,476	24,370,278
Warrants
Potentially dilutive securities excluded from computation of diluted net loss per share
Anti-dilutive securities (in shares)	16,351,314	16,351,314
Stock options
Potentially dilutive securities excluded from computation of diluted net loss per share
Anti-dilutive securities (in shares)	4,746,108	8,018,964
Restricted stock units
Potentially dilutive securities excluded from computation of diluted net loss per share
Anti-dilutive securities (in shares)	3,748,054	0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss)
Balance at the beginning of period	$ (54,408)	$ (45,519)	$ (7,685)	$ (195,346)
Other comprehensive loss				1,887
Amounts reclassified from accumulated other comprehensive net loss				(2,177)
Net current period other comprehensive loss		(145)		(290)
Balance at the end of period	(57,931)	(54,408)	(19,963)	(7,685)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss)
Balance at the beginning of period	(10,265)	(10,120)	(9,595)	(9,305)
Net current period other comprehensive loss	(174)		(1,220)
Balance at the end of period	(10,439)	(10,265)	(10,815)	(9,595)
Foreign Currency Translation
Accumulated Other Comprehensive Income (Loss)
Balance at the beginning of period	(10,265)	(10,120)	(9,595)	(11,482)
Other comprehensive loss				1,887
Amounts reclassified from accumulated other comprehensive net loss				0
Net current period other comprehensive loss	(174)	(145)	(1,220)	1,887
Balance at the end of period	(10,439)	(10,265)	(10,815)	(9,595)
Net Unrealized Gain (Loss) on Securities
Accumulated Other Comprehensive Income (Loss)
Balance at the beginning of period	0	0	0	2,177
Other comprehensive loss				0
Amounts reclassified from accumulated other comprehensive net loss				(2,177)
Net current period other comprehensive loss	0			(2,177)
Balance at the end of period	$ 0	$ 0	$ 0	$ 0

Restructuring and other charg_3

Restructuring and other charges - Narrative (Details) $ in Thousands		3 Months Ended		6 Months Ended
	Oct. 12, 2023 position	Mar. 31, 2024 USD ($) position	Mar. 31, 2023 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Restructuring and Related Activities [Abstract]
Expected number of positions eliminated	84
Restructuring and other charges \| $		$ 475	$ 0	$ 3,242	$ 0
Restructuring and Related Cost, Number of Positions Eliminated		12

Restructuring and other charg_4

Restructuring and other charges - Summary of Accrued Restructuring and Other Charges (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Restructuring Reserve [Roll Forward]
Balance, beginning of period			$ 0
Restructuring and other charges	$ 475	$ 0	3,242	$ 0
Cash payments			(2,940)
Balance, end of period	$ 302		$ 302

Divestitures (Details)

Divestitures (Details) - USD ($) $ in Thousands		3 Months Ended			6 Months Ended
Divestitures (Details) - USD ($) $ in Thousands	Nov. 17, 2023	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on divestitures		$ (134)		$ 0	$ 799	$ 0
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| SkyDB, Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Minority interest to be issued	10%
Non-competition covenant term	12 months
Net revenue to be received, percent	30%
Gain on divestitures			$ 900
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| CubeWerx
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loan obligation							$ 600
Ownership obligation							10%